From toxins targeting ligand gated ion channels to therapeutic molecules

Toxins

Volumn 3, Issue 3, 2011, Pages 260-293

  Nasiripourdori, Adak ^a   Taly, Valérie ^b   Grutter, Thomas ^b   Taly, Antoine ^b  

^a ARAK UNIVERSITY   (Iran)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

AMPA; GABA; Glycine; Kainate; nAChR; NMDA; P2x; Serotonin

Indexed keywords

3 (2,4 DIMETHOXYBENZYLIDENE)ANABASEINE; 4 AMINOBUTYRIC ACID A RECEPTOR; ALPHA BUNGAROTOXIN; AMPA RECEPTOR; CONANTOKIN G; CONANTOKIN T; CONOTOXIN; CYTISINE; EPIBATIDINE; ION CHANNEL; KAINIC ACID; KAINIC ACID RECEPTOR; LIGAND GATED ION CHANNEL; LOBELINE; MECAMYLAMINE; METHYLLYCACONITINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICOTINIC AGENT; NICOTINIC RECEPTOR; PICROTOXIN; PURINERGIC P2X RECEPTOR; SEROTONIN RECEPTOR; SNAKE VENOM; STRYCHNINE; TC 5214; TEBANICLINE; UNCLASSIFIED DRUG;

ASCARIASIS; ATTENTION DEFICIT DISORDER; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR DEPRESSION; MOLECULARLY TARGETED THERAPY; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; NONHUMAN; PAIN; PARKINSON DISEASE; PROTEIN TARGETING; REVIEW; SARCOIDOSIS; SCHIZOPHRENIA; STRUCTURE ANALYSIS; TOBACCO DEPENDENCE; TOXIN ANALYSIS; TOXIN STRUCTURE; UNSPECIFIED SIDE EFFECT;

AMPA; GABA; GLYCINE; KAINATE; NACHR; NMDA; P2X; SEROTONIN;

ANIMALS; BINDING SITES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DISCOVERY; HUMANS; LIGAND-GATED ION CHANNELS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PROTEIN BINDING; TOXINS, BIOLOGICAL;

ANIMALIA;

EID: 79953236096     PISSN: None     EISSN: 20726651     Source Type: Journal    
DOI: 10.3390/toxins3030260     Document Type: Review

References (212)

1. Bisset, N.G. One man's poison, another man's medicine? J. Ethnopharmacol. 1991, 32, 71-81.
2. Rainsford, K.D. Ibuprofen: Pharmacology, efficacy and safety. Inflammopharmacology 2009, 17, 275-342.
3. Livett, B.G.; Sandall, D.W.; Keays, D.; Down, J.; Gayler, K.R.; Satkunanathan, N.; Khalil, Z. Therapeutic applications of conotoxins that target the neuronal nicotinic acetylcholine receptor. Toxicon 2006, 48, 810-829.
4. Lewis, R.J.; Garcia, M.L. Therapeutic potential of venom peptides. Nat. Rev. Drug. Discov. 2003, 2, 790-802.
5. Brieger, L. Zur Kenntniss der Aetiologie des Wundstarrkrampfes nebst Bemerkungen über das Choleraroth. Dtsch. Med. Wochenschr 1887, 13, 303-305.
6. Pastan, I.; Chaudhary, V.; FitzGerald, D.J. Recombinant toxins as novel therapeutic agents. Annu. Rev. Biochem. 1992, 61, 331-354.
7. Changeux, J.P.; Taly, A. Nicotinic receptors, allosteric proteins and medicine. Trends. Mol. Med. 2008, 14, 93-102.
8. Collingridge, G.L.; Olsen, R.W.; Peters, J.; Spedding, M. A nomenclature for ligand-gated ion channels. Neuropharmacology 2009, 56, 2-5.
9. Karlin, A. Emerging structure of the nicotinic acetylcholine receptors. Nat. Rev. Neurosci. 2002, 3, 102-114.
10. Le Novere, N.; Changeux, J.P. LGICdb: The ligand-gated ion channel database. Nucleic. Acids. Res. 2001, 29, 294-295.
11. Baenziger, J.E.; Corringer, P.J. 3D structure and allosteric modulation of the transmembrane domain of pentameric ligand-gated ion channels. Neuropharmacology 2011, 60, 116-125.
12. Traynelis, S.F.; Wollmuth, L.P.; McBain, C.J.; Menniti, F.S.; Vance, K.M.; Ogden, K.K.; Hansen, K.B.; Yuan, H.; Myers, S.J.; Dingledine, R. Glutamate receptor ion channels: Structure, regulation, and function. Pharmacol. Rev. 2010, 62, 405-496.
13. Bernard, C. Leçons sur les effets des substances toxiques et m édicamenteuses; Collège de France: Paris, France, 1857.
14. Angenot, L.; Denoel, A.; Goffart, M. Curare-like effect of African Strychnos: Strychnos usambarensis Gilg du Rwanda. J. Pharm. Belg. 1970, 25, 73-77.
15. Bisset, N.G. War and hunting poisons of the New World. Part 1. Notes on the early history of curare. J. Ethnopharmacol. 1992, 36, 1-26.
16. Langley, J.N. On nerve ending and on special excitable substances in cells. Proc. Roy. Soc. Ser. B 1906, 78, 170-194.
17. Changeux, J.-P.; Edelstein, S.J. Nicotinic Acetylcholine Receptors: From Molecular Biology to Cognition; Odile Jacob: New York, NY, USA, 2005; p. 284.
18. Changeux, J.P.; Kasai, M.; Huchet, M.; Meunier, J.C. Extraction from electric tissue of gymnotus of a protein presenting several typical properties characteristic of the physiological receptor of acetylcholine. C. R. Acad. Sci. Hebd. Seances. Acad. Sci. D 1970, 270, 2864-2867.
19. Changeux, J.P.; Podleski, T.R.; Wofsy, L. Affinity labeling of the acetylcholine-receptor. Proc. Natl. Acad. Sci. USA 1967, 58, 2063-2070.
20. Favreau, P.; Le Gall, F.; Benoit, E.; Molgo, J. A review on conotoxins targeting ion channels and acetylcholine receptors of the vertebrate neuromuscular junction. Acta. Physiol. Pharmacol. Ther. Latinoam. 1999, 49, 257-267.
21. Vogel, Z.; Sytkowski, A.J.; Nirenberg, M.W. Acetylcholine receptors of muscle grown in vitro. Proc. Natl. Acad. Sci. USA 1972, 69, 3180-3184.
22. Morris, C.E.; Harrison, J.B. Central nervous system features of a nicotine-resistant insect, the tobacco hornworm Manduca sexta. Tissue Cell 1984, 16, 601-612.
23. Dale, H.H. The action of certain esters and ethers of choline, and their relation to muscarine. J. Pharmacol. Exp. Ther 1914, 6, 147-190.
24. Tomizawa, M.; Casida, J.E. Molecular recognition of neonicotinoid insecticides: The determinants of life or death. Acc. Chem. Res 2009, 42, 260-269.
25. Matolcsy, G.; Nádasy, M.; Andriska, V. Pesticide Chemistry; Elsevier: Amsterdam, The Netherlands, 1988; p. 808.
26. Maskos, U.; Molles, B.E.; Pons, S.; Besson, M.; Guiard, B.P.; Guilloux, J.P.; Evrard, A.; Cazala, P.; Cormier, A.; Mameli-Engvall, M.; Dufour, N.; Cloez-Tayarani, I.; Bemelmans, A.P.; Mallet, J.; Gardier, A.M.; David, V.; Faure, P.; Granon, S.; Changeux, J.P. Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature 2005, 436, 103-107.
27. Marshall, I.G.; Harvey, A.L. Selective neuromuscular blocking properties of alpha-conotoxins in vivo. Toxicon 1990, 28, 231-234.
28. Arias, H.R.; Blanton, M.P. Alpha-conotoxins. Int. J. Biochem. Cell Biol. 2000, 32, 1017-1028.
29. McIntosh, J.M.; Santos, A.D.; Olivera, B.M. Conus peptides targeted to specific nicotinic acetylcholine receptor subtypes. Annu. Rev. Biochem. 1999, 68, 59-88.
30. Ellison, M.; McIntosh, J.M.; Olivera, B.M. Alpha-conotoxins ImI and ImII. Similar alpha. 7 nicotinic receptor antagonists act at different sites. J. Biol. Chem. 2003, 278, 757-764.
31. Azam, L.; Dowell, C.; Watkins, M.; Stitzel, J.A.; Olivera, B.M.; McIntosh, J.M. Alpha-conotoxin BuIA, a novel peptide from Conus bullatus, distinguishes among neuronal nicotinic acetylcholine receptors. J. Biol. Chem. 2005, 280, 80-87.
32. Favreau, P.; Krimm, I.; Le Gall, F.; Bobenrieth, M.J.; Lamthanh, H.; Bouet, F.; Servent, D.; Molgo, J.; Menez, A.; Letourneux, Y.; Lancelin, J.M. Biochemical characterization and nuclear magnetic resonance structure of novel alpha-conotoxins isolated from the venom of Conus consors. Biochemistry 1999, 38, 6317-6326.
33. Liu, L.; Chew, G.; Hawrot, E.; Chi, C.; Wang, C. Two potent alpha3/5 conotoxins from piscivorous Conus achatinus. Acta Biochim. Biophys. Sin (Shanghai) 2007, 39, 438-444.
34. Martinez, J.S.; Olivera, B.M.; Gray, W.R.; Craig, A.G.; Groebe, D.R.; Abramson, S.N.; McIntosh, J.M. alpha-Conotoxin EI, a new nicotinic acetylcholine receptor antagonist with novel selectivity. Biochemistry 1995, 34, 14519-14526.
35. Hogg, R.C.; Miranda, L.P.; Craik, D.J.; Lewis, R.J.; Alewood, P.F.; Adams, D.J. Single amino acid substitutions in alpha-conotoxin PnIA shift selectivity for subtypes of the mammalian neuronal nicotinic acetylcholine receptor. J. Biol. Chem. 1999, 274, 36559-36564.
36. Luo, S.; Nguyen, T.A.; Cartier, G.E.; Olivera, B.M.; Yoshikami, D.; McIntosh, J.M. Single-residue alteration in alpha-conotoxin PnIA switches its nAChR subtype selectivity. Biochemistry 1999, 38, 14542-14548.
37. McIntosh, J.M.; Dowell, C.; Watkins, M.; Garrett, J.E.; Yoshikami, D.; Olivera, B.M. Alpha-conotoxin GIC from Conus geographus, a novel peptide antagonist of nicotinic acetylcholine receptors. J. Biol. Chem. 2002, 277, 33610-33615.
38. Cartier, G.E.; Yoshikami, D.; Gray, W.R.; Luo, S.; Olivera, B.M.; McIntosh, J.M. A new alpha-conotoxin which targets alpha3beta2 nicotinic acetylcholine receptors. J. Biol. Chem. 1996, 271, 7522-7528.
39. McIntosh, J.M.; Azam, L.; Staheli, S.; Dowell, C.; Lindstrom, J.M.; Kuryatov, A.; Garrett, J.E.; Marks, M.J.; Whiteaker, P. Analogs of alpha-conotoxin MII are selective for alpha6-containing nicotinic acetylcholine receptors. Mol. Pharmacol. 2004, 65, 944-952.
40. Dowell, C.; Olivera, B.M.; Garrett, J.E.; Staheli, S.T.; Watkins, M.; Kuryatov, A.; Yoshikami, D.; Lindstrom, J.M.; McIntosh, J.M. Alpha-conotoxin PIA is selective for alpha6 subunit-containing nicotinic acetylcholine receptors. J. Neurosci. 2003, 23, 8445-8452.
41. Lopez-Vera, E.; Jacobsen, R.B.; Ellison, M.; Olivera, B.M.; Teichert, R.W. A novel alpha conotoxin (alpha-PIB) isolated from C. purpurascens is selective for skeletal muscle nicotinic acetylcholine receptors. Toxicon 2007, 49, 1193-1199.
42. Dutertre, S.; Nicke, A.; Lewis, R.J. Beta2 subunit contribution to. 4/7 alpha-conotoxin binding to the nicotinic acetylcholine receptor. J. Biol. Chem. 2005, 280, 30460-30468.
43. Nicke, A.; Loughnan, M.L.; Millard, E.L.; Alewood, P.F.; Adams, D.J.; Daly, N.L.; Craik, D.J.; Lewis, R.J. Isolation, structure, and activity of GID, a novel alpha. 4/7-conotoxin with an extended N-terminal sequence. J. Biol. Chem. 2003, 278, 3137-3144.
44. Nicke, A.; Wonnacott, S.; Lewis, R.J. Alpha-conotoxins as tools for the elucidation of structure and function of neuronal nicotinic acetylcholine receptor subtypes. Eur. J. Biochem. 2004, 271, 2305-2319.
45. Loughnan, M.; Bond, T.; Atkins, A.; Cuevas, J.; Adams, D.J.; Broxton, N.M.; Livett, B.G.; Down, J.G.; Jones, A.; Alewood, P.F.; Lewis, R.J. alpha-conotoxin EpI, a novel sulfated peptide from Conus episcopatus that selectively targets neuronal nicotinic acetylcholine receptors. J. Biol. Chem. 1998, 273, 15667-15674.
46. Nicke, A.; Samochocki, M.; Loughnan, M.L.; Bansal, P.S.; Maelicke, A.; Lewis, R.J. Alpha-conotoxins EpI and AuIB switch subtype selectivity and activity in native versus recombinant nicotinic acetylcholine receptors. FEBS Lett. 2003, 554, 219-223.
47. Loughnan, M.L.; Nicke, A.; Jones, A.; Adams, D.J.; Alewood, P.F.; Lewis, R.J. Chemical and functional identification and characterization of novel sulfated alpha-conotoxins from the cone snail Conus anemone. J. Med. Chem. 2004, 47, 1234-1241.
48. Vincler, M.; Wittenauer, S.; Parker, R.; Ellison, M.; Olivera, B.M.; McIntosh, J.M. Molecular mechanism for analgesia involving specific antagonism of alpha9alpha10 nicotinic acetylcholine receptors. Proc. Natl. Acad. Sci. USA 2006, 103, 17880-17884.
49. Clark, R.J.; Fischer, H.; Nevin, S.T.; Adams, D.J.; Craik, D.J. The synthesis, structural characterization, and receptor specificity of the alpha-conotoxin Vc1.1. J. Biol. Chem. 2006, 281, 23254-23263.
50. Whiteaker, P.; Christensen, S.; Yoshikami, D.; Dowell, C.; Watkins, M.; Gulyas, J.; Rivier, J.; Olivera, B.M.; McIntosh, J.M. Discovery, synthesis, and structure activity of a highly selective alpha7 nicotinic acetylcholine receptor antagonist. Biochemistry 2007, 46, 6628-6638.
51. McIntosh, J.M.; Plazas, P.V.; Watkins, M.; Gomez-Casati, M.E.; Olivera, B.M.; Elgoyhen, A.B. A novel alpha-conotoxin, PeIA, cloned from Conus pergrandis, discriminates between rat alpha9 alpha10 and alpha7 nicotinic cholinergic receptors. J. Biol. Chem. 2005, 280, 30107-30112.
52. Talley, T.T.; Olivera, B.M.; Han, K.H.; Christensen, S.B.; Dowell, C.; Tsigelny, I.; Ho, K.Y.; Taylor, P.; McIntosh, J.M. Alpha-conotoxin OmIA is a potent ligand for the acetylcholine-binding protein as well as alpha3beta2 and alpha7 nicotinic acetylcholine receptors. J. Biol. Chem. 2006, 281, 24678-24686.
53. Dutertre, S.; Ulens, C.; Buttner, R.; Fish, A.; van Elk, R.; Kendel, Y.; Hopping, G.; Alewood, P.F.; Schroeder, C.; Nicke, A.; Smit, A.B.; Sixma, T.K.; Lewis, R.J. AChBP-targeted alpha-conotoxin correlates distinct binding orientations with nAChR subtype selectivity. EMBO J. 2007, 26, 3858-3867.
54. Peng, C.; Han, Y.; Sanders, T.; Chew, G.; Liu, J.; Hawrot, E.; Chi, C.; Wang, C. alpha4/7-conotoxin Lp1.1 is a novel antagonist of neuronal nicotinic acetylcholine receptors. Peptides 2008, 29, 1700-1707.
55. Lopez-Vera, E.; Aguilar, M.B.; Schiavon, E.; Marinzi, C.; Ortiz, E.; Restano Cassulini, R.; Batista, C.V.; Possani, L.D.; Heimer de la Cotera, E.P.; Peri, F.; Becerril, B.; Wanke, E. Novel alpha-conotoxins from Conus spurius and the alpha-conotoxin EI share high-affinity potentiation and low-affinity inhibition of nicotinic acetylcholine receptors. FEBS J. 2007, 274, 3972-3985.
56. Dwoskin, L.P.; Crooks, P.A. Competitive neuronal nicotinic receptor antagonists: A new direction for drug discovery. J. Pharmacol. Exp. Ther. 2001, 298, 395-402.
57. Lukas, R.J. Pharmacological distinctions between functional nicotinic acetylcholine receptors on the PC12 rat pheochromocytoma and the TE671 human medulloblastoma. J. Pharmacol. Exp. Ther. 1989, 251, 175-182.
58. Decker, M.W.; Anderson, D.J.; Brioni, J.D.; Donnelly-Roberts, D.L.; Kang, C.H.; O'Neill, A.B.; Piattoni-Kaplan, M.; Swanson, S.; Sullivan, J.P. Erysodine, a competitive antagonist at neuronal nicotinic acetylcholine receptors. Eur. J. Pharmacol. 1995, 280, 79-89.
59. Fitch, R.W.; Xiao, Y.; Kellar, K.J.; Daly, J.W. Membrane potential fluorescence: A rapid and highly sensitive assay for nicotinic receptor channel function. Proc. Natl. Acad. Sci. USA 2003, 100, 4909-4914.
60. Aiyar, V.N.; Benn, M.H.; Hanna, T.; Jacyno, J.; Roth, S.H.; Wilkens, J.L. The principal toxin of Delphinium brownii Rydb., and its mode of action. Experientia 1979, 35, 1367-1368.
61. Macallan, D.R.; Lunt, G.G.; Wonnacott, S.; Swanson, K.L.; Rapoport, H.; Albuquerque, E.X. Methyllycaconitine and (+)-anatoxin-a differentiate between nicotinic receptors in vertebrate and invertebrate nervous systems. FEBS Lett. 1988, 226, 357-363.
62. Ward, J.M.; Cockcroft, V.B.; Lunt, G.G.; Smillie, F.S.; Wonnacott, S. Methyllycaconitine: A selective probe for neuronal alpha-bungarotoxin binding sites. FEBS Lett. 1990, 270, 45-48.
63. Kukel, C.F.; Jennings, K.R. Delphinium alkaloids as inhibitors of alpha-bungarotoxin binding to rat and insect neural membranes. Can. J. Physiol. Pharmacol. 1994, 72, 104-107.
64. Dobelis, P.; Madl, J.E.; Pfister, J.A.; Manners, G.D.; Walrond, J.P. Effects of Delphinium alkaloids on neuromuscular transmission. J. Pharmacol. Exp. Ther. 1999, 291, 538-546.
65. Pfister, J.A.; Gardner, D.R.; Panter, K.E.; Manners, G.D.; Ralphs, M.H.; Stegelmeier, B.L.; Schoch, T.K. Larkspur (Delphinium spp.) poisoning in livestock. J. Nat. Toxins 1999, 8, 81-94.
66. Stromgaard, K. Natural products as tools for studies of ligand-gated ion channels. Chem. Rec. 2005, 5, 229-239.
67. Hold, K.M.; Sirisoma, N.S.; Ikeda, T.; Narahashi, T.; Casida, J.E. Alpha-thujone (the active component of absinthe): Gamma-aminobutyric acid type A receptor modulation and metabolic detoxification. Proc. Natl. Acad. Sci. USA 2000, 97, 3826-3831.
68. Deiml, T.; Haseneder, R.; Zieglgansberger, W.; Rammes, G.; Eisensamer, B.; Rupprecht, R.; Hapfelmeier, G. Alpha-thujone reduces. 5-HT3 receptor activity by an effect on the agonist-reduced desensitization. Neuropharmacology 2004, 46, 192-201.
69. Chen, H.K.; Su, C.K. Endogenous activation of nicotinic receptors underlies sympathetic tone generation in neonatal rat spinal cord in vitro. Neuropharmacology 2006, 51, 1120-1128.
70. Erkkila, B.E.; Sedelnikova, A.V.; Weiss, D.S. Stoichiometric pore mutations of the GABAAR reveal a pattern of hydrogen bonding with picrotoxin. Biophys. J. 2008, 94, 4299-4306.
71. Charon, S.; Taly, A.; Rodrigo, J.; Perret, P.; Goeldner, M. Binding Modes of Noncompetitive GABA-Channel Blockers Revisited Using Engineered Affinity-Labeling Reactions Combined with New Docking Studies (dagger). J. Agric. Food Chem. 2010, doi:10,1021/jf102468n.
72. Johnson, J.W.; Ascher, P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 1987, 325, 529-531.
73. England, L.J.; Imperial, J.; Jacobsen, R.; Craig, A.G.; Gulyas, J.; Akhtar, M.; Rivier, J.; Julius, D.; Olivera, B.M. Inactivation of a serotonin-gated ion channel by a polypeptide toxin from marine snails. Science. 1998, 281, 575-578.
74. Yan, D.; White, M.M. Interaction of d-tubocurarine analogs with mutant 5-HT(3) receptors. Neuropharmacology 2002, 43, 367-373.
75. Griffith, H.R.; Johnson, G. The use of curare in general anasthesia. Anesthesiology 1942, 3, 418-420.
76. Parks, T.N.; Mueller, A.L.; Artman, L.D.; Albensi, B.C.; Nemeth, E.F.; Jackson, H.; Jasys, V.J.; Saccomano, N.A.; Volkmann, R.A. Arylamine toxins from funnel-web spider (Agelenopsis aperta) venom antagonize N-methyl-D-aspartate receptor function in mammalian brain. J. Biol. Chem. 1991, 266, 21523-21529.
77. Kiskin, N.I.; Chizhmakov, I.V.; Tsyndrenko, A.; Mueller, A.L.; Jackson, H.; Krishtal, O.A. A highly potent and selective N-methyl-D-aspartate receptor antagonist from the venom of the Agelenopsis aperta spider. Neuroscience 1992, 51, 11-18.
78. Frydenvang, K.; Lash, L.L.; Naur, P.; Postila, P.A.; Pickering, D.S.; Smith, C.M.; Gajhede, M.; Sasaki, M.; Sakai, R.; Pentikainen, O.T.; Swanson, G.T.; Kastrup, J.S. Full domain closure of the ligand-binding core of the ionotropic glutamate receptor iGluR5 induced by the high affinity agonist dysiherbaine and the functional antagonist. 8,9-dideoxyneodysiherbaine. J. Biol. Chem. 2009, 284, 14219-14229.
79. Rajendra, W.; Armugam, A.; Jeyaseelan, K. Toxins in anti-nociception and anti-inflammation. Toxicon 2004, 44, 1-17.
80. Sheng, Z.; Prorok, M.; Castellino, F.J. Specific determinants of conantokins that dictate their selectivity for the NR2B subunit of N-methyl-D-aspartate receptors. Neuroscience 2010, 170, 703-710.
81. Skjaerbaek, N.; Nielsen, K.J.; Lewis, R.J.; Alewood, P.; Craik, D.J. Determination of the solution structures of conantokin-G and conantokin-T by CD and NMR spectroscopy. J. Biol. Chem. 1997, 272, 2291-2299.
82. Dai, Q.; Xiao, C.; Dong, M.; Liu, Z.; Sheng, Z.; Castellino, F.J.; Prorok, M. Non-strict strand orientation of the Ca2+-induced dimerization of a conantokin peptide variant with sequence-shifted gamma-carboxyglutamate residues. Peptides 2009, 30, 866-872.
83. Lodge, D. The history of the pharmacology and cloning of ionotropic glutamate receptors and the development of idiosyncratic nomenclature. Neuropharmacology 2009, 56, 6-21.
84. Sakai, R.; Minato, S.; Koike, K.; Jimbo, M.; Kamiya, H. Cellular and subcellular localization of kainic acid in the marine red alga Digenea simplex. Cell Tissue Res. 2005, 322, 491-502.
85. Swanson, G.T.; Green, T.; Sakai, R.; Contractor, A.; Che, W.; Kamiya, H.; Heinemann, S.F. Differential activation of individual subunits in heteromeric kainate receptors. Neuron 2002, 34, 589-598.
86. Savchenko, H.A.; Vasylevs'kyi, A.A.; Pluzhnykov, K.A.; Korolkova Iu, V.; Mamenko, M.V.; Volkova, T.M.; Maksymiuk, O.P.; Boichuk Ia, A.; Hrishyn Ie, V.; Kryshtal, O.O. Peptide components of Geolycosa spider venom modulate P2X receptor activity of rat sensory neurons. Fiziol. Zh. 2009, 55, 11-16.
87. Grishin, E.V.; Savchenko, G.A.; Vassilevski, A.A.; Korolkova, Y.V.; Boychuk, Y.A.; Viatchenko-Karpinski, V.Y.; Nadezhdin, K.D.; Arseniev, A.S.; Pluzhnikov, K.A.; Kulyk, V.B.; Voitenko, N.V.; Krishtal, O.O. Novel peptide from spider venom inhibits P2X3 receptors and inflammatory pain. Ann. Neurol. 2010, 67, 680-683.
88. Patyar, S.; Joshi, R.; Byrav, D.S.; Prakash, A.; Medhi, B.; Das, B.K. Bacteria in cancer therapy: A novel experimental strategy. J. Biomed. Sci. 2010, 17, 21.
89. Shapira, A.; Benhar, I. Toxin-Based Therapeutic Approaches. Toxins 2010, 2, 2519-2583.
90. Tutka, P.; Zatonski, W. Cytisine for the treatment of nicotine addiction: From a molecule to therapeutic efficacy. Pharmacol. Rep. 2006, 58, 777-798.
91. Cohen, C.; Bergis, O.E.; Galli, F.; Lochead, A.W.; Jegham, S.; Biton, B.; Leonardon, J.; Avenet, P.; Sgard, F.; Besnard, F.; Graham, D.; Coste, A.; Oblin, A.; Curet, O.; Voltz, C.; Gardes, A.; Caille, D.; Perrault, G.; George, P.; Soubrie, P.; Scatton, B. SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessation. J. Pharmacol. Exp. Ther. 2003, 306, 407-420.
92. Martin, L.F.; Kem, W.R.; Freedman, R. Alpha-7 nicotinic receptor agonists: Potential new candidates for the treatment of schizophrenia. Psychopharmacology (Berl) 2004, 174, 54-64.
93. Wei, S., Qiu, L., Chen, Z.H., Xu, M.C. Effect observation of Snake venom point injection in the treatment of scapulohumeral periarthritis. Chin. J. Infor. Traditional Chin. Med. 2007, 14, 68-96.
94. Grozio, A.; Paleari, L.; Catassi, A.; Servent, D.; Cilli, M.; Piccardi, F.; Paganuzzi, M.; Cesario, A.; Granone, P.; Mourier, G.; Russo, P. Natural agents targeting the alpha7-nicotinic-receptor in NSCLC: A promising prospective in anti-cancer drug development. Int. J. Cancer. 2008, 122, 1911-1915.
95. Spindel, E.R. Is nicotine the estrogen of lung cancer? Am. J. Respir. Crit. Care. Med. 2009, 179, 1081-1082.
96. Paleari, L.; Negri, E.; Catassi, A.; Cilli, M.; Servent, D.; D'Angelillo, R.; Cesario, A.; Russo, P.; Fini, M. Inhibition of non neuronal alpha7-nicotinic receptor for lung cancer treatment. Am. J. Respir. Crit. Care. Med. 2009, 179, 1141-1150.
97. Catassi, A.; Paleari, L.; Servent, D.; Sessa, F.; Dominioni, L.; Ognio, E.; Cilli, M.; Vacca, P.; Mingari, M.; Gaudino, G.; Bertino, P.; Paolucci, M.; Calcaterra, A.; Cesario, A.; Granone, P.; Costa, R.; Ciarlo, M.; Alama, A.; Russo, P. Targeting alpha7-nicotinic receptor for the treatment of pleural mesothelioma. Eur. J. Cancer. 2008, 44, 2296-2311.
98. Russo, P.; Catassi, A.; Cesario, A.; Servent, D. Development of novel therapeutic strategies for lung cancer: Targeting the cholinergic system. Curr. Med. Chem. 2006, 13, 3493-3512.
99. Chen, Z.X.; Zhang, H.L.; Gu, Z.L.; Chen, B.W.; Han, R.; Reid, P.F.; Raymond, L.N.; Qin, Z.H. A long-form alpha-neurotoxin from cobra venom produces potent opioid-independent analgesia. Acta Pharmacol. Sin. 2006, 27, 402-408.
100. Reid, P.F. Alpha-cobratoxin as a possible therapy for multiple sclerosis: A review of the literature leading to its development for this application. Crit. Rev. Immunol. 2007, 27, 291-302.
101. Zhang, H.L.; Han, R.; Chen, Z.X.; Gu, Z.L.; Reid, P.F.; Raymond, L.N.; Qin, Z.H. Analgesic effects of receptin, a chemically modified cobratoxin from Thailand cobra venom. Neurosci. Bull. 2006, 22, 267-273.
102. Nevin, S.T.; Clark, R.J.; Klimis, H.; Christie, M.J.; Craik, D.J.; Adams, D.J. Are alpha9alpha10 nicotinic acetylcholine receptors a pain target for alpha-conotoxins? Mol. Pharmacol. 2007, 72, 1406-1410.
103. Callaghan, B.; Haythornthwaite, A.; Berecki, G.; Clark, R.J.; Craik, D.J.; Adams, D.J. Analgesic alpha-conotoxins Vc1.1 and Rg1A inhibit N-type calcium channels in rat sensory neurons via GABAB receptor activation. J. Neurosci. 2008, 28, 10943-10951.
104. Azam, L.; McIntosh, J.M. Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors. Acta. Pharmacol. Sin. 2009, 30, 771-783.
105. Tuba, Z.; Maho, S.; Vizi, E.S. Synthesis and structure-activity relationships of neuromuscular blocking agents. Curr. Med. Chem. 2002, 9, 1507-1536.
106. Hughes, T. The early history of myasthenia gravis. Neuromuscul. Disord. 2005, 15, 878-886.
107. Vincent, A. Unravelling the pathogenesis of myasthenia gravis. Nat. Rev. Immunol. 2002, 2, 797-804.
108. Engel, A.G.; Sine, S.M. Current understanding of congenital myasthenic syndromes. Curr. Opin. Pharmacol. 2005, 5, 308-321.
109. Garcia-Colunga, J.; Miledi, R. Modulation of nicotinic acetylcholine receptors by strychnine. Proc. Natl. Acad. Sci. USA 1999, 96, 4113-4118.
110. Verkman, A.S.; Galietta, L.J. Chloride channels as drug targets. Nat. Rev. Drug. Discov. 2009, 8, 153-171.
111. Laube, B.; Maksay, G.; Schemm, R.; Betz, H. Modulation of glycine receptor function: A novel approach for therapeutic intervention at inhibitory synapses? Trends Pharmacol. Sci. 2002, 23, 519-527.
112. Walstab, J.; Rappold, G.; Niesler, B. 5-HT(3) receptors: Role in disease and target of drugs. Pharmacol. Ther. 2010, 128, 146-169.
113. Koller, M.; Urwyler, S. Novel N-methyl-D-aspartate receptor antagonists: A review of compounds patented since. 2006. Expert. Opin. Ther. Pat. 2010, 20, 1683-1702.
114. Malmberg, A.B.; Gilbert, H.; McCabe, R.T.; Basbaum, A.I. Powerful antinociceptive effects of the cone snail venom-derived subtype-selective NMDA receptor antagonists conantokins G and T. Pain 2003, 101, 109-116.
115. Hama, A.; Sagen, J. Antinociceptive effects of the marine snail peptides conantokin-G and conotoxin MVIIA alone and in combination in rat models of pain. Neuropharmacology 2009, 56, 556-563.
116. Jimenez, E.C.; Donevan, S.; Walker, C.; Zhou, L.M.; Nielsen, J.; Cruz, L.J.; Armstrong, H.; White, H.S.; Olivera, B.M. Conantokin-L, a new NMDA receptor antagonist: Determinants for anticonvulsant potency. Epilepsy Res. 2002, 51, 73-80.
117. Prorok, M.; Castellino, F.J. The molecular basis of conantokin antagonism of NMDA receptor function. Curr. Drug. Targets. 2007, 8, 633-642.
118. Swanson, G.T.; Sakai, R. Ligands for ionotropic glutamate receptors. Prog. Mol. SubCell Biol. 2009, 46, 123-157.
119. Li, Z.; Liang, D.; Chen, L. Potential therapeutic targets for ATP-gated P2X receptor ion channels. Assay Drug. Dev. Technol. 2008, 6, 277-284.
120. Gunosewoyo, H.; Kassiou, M. P2X purinergic receptor ligands: Recently patented compounds. Expert Opin. Ther. Pat. 2010, 20, 625-646.
121. Ryan, T.J.; Grant, S.G. The origin and evolution of synapses. Nat. Rev. Neurosci. 2009, 10, 701-712.
122. Tasneem, A.; Iyer, L.M.; Jakobsson, E.; Aravind, L. Identification of the prokaryotic ligandgated ion channels and their implications for the mechanisms and origins of animal Cys-loop ion channels. Genome. Biol. 2005, 6, R4.
123. Bocquet, N.; Prado de Carvalho, L.; Cartaud, J.; Neyton, J.; Le Poupon, C.; Taly, A.; Grutter, T.; Changeux, J.P.; Corringer, P.J. A prokaryotic proton-gated ion channel from the nicotinic acetylcholine receptor family. Nature 2007, 445, 116-119.
124. Chen, G.Q.; Cui, C.; Mayer, M.L.; Gouaux, E. Functional characterization of a potassium-selective prokaryotic glutamate receptor. Nature 1999, 402, 817-821.
125. Osborne, R.H. Insect neurotransmission: Neurotransmitters and their receptors. Pharmacol. Ther. 1996, 69, 117-142.
126. Ryten, M.; Koshi, R.; Knight, G.E.; Turmaine, M.; Dunn, P.; Cockayne, D.A.; Ford, A.P.; Burnstock, G. Abnormalities in neuromuscular junction structure and skeletal muscle function in mice lacking the P2X2 nucleotide receptor. Neuroscience 2007, 148, 700-711.
127. Adams, D.J., Alewoodb, P.F., Craikb, D.J., Drinkwaterc, R.D. and R.J. Lewis. Conotoxins and Their Potential Pharmaceutical Applications. Drug Dev. Res. 1999, 46, 219-234.
128. Moise, L.; Piserchio, A.; Basus, V.J.; Hawrot, E. NMR structural analysis of alpha-bungarotoxin and its complex with the principal alpha-neurotoxin-binding sequence on the alpha. 7 subunit of a neuronal nicotinic acetylcholine receptor. J. Biol. Chem. 2002, 277, 12406-12417.
129. Samson, A.; Scherf, T.; Eisenstein, M.; Chill, J.; Anglister, J. The mechanism for acetylcholine receptor inhibition by alpha-neurotoxins and species-specific resistance to alpha-bungarotoxin revealed by NMR. Neuron 2002, 35, 319-332.
130. Osaka, H.; Malany, S.; Molles, B.E.; Sine, S.M.; Taylor, P. Pairwise electrostatic interactions between alpha-neurotoxins and gamma, delta, and epsilon subunits of the nicotinic acetylcholine receptor. J. Biol. Chem. 2000, 275, 5478-5484.
131. Servent, D.; Menez, A. Snake neurotoxins that interact with nicotinic acetylcholine receptors. In Handbook of Neurotoxicology; Humana Press Inc.: Totowa, NJ, USA, 2001; pp. 385-425.
132. Zeng, H.; Hawrot, E. NMR-based binding screen and structural analysis of the complex formed between alpha-cobratoxin and an 18-mer cognate peptide derived from the alpha 1 subunit of the nicotinic acetylcholine receptor from Torpedo californica. J. Biol. Chem. 2002, 277, 37439-37445.
133. Low, B.W.; Preston, H.S.; Sato, A.; Rosen, L.S.; Searl, J.E.; Rudko, A.D.; Richardson, J.S. Three dimensional structure of erabutoxin b neurotoxic protein: Inhibitor of acetylcholine receptor. Proc. Natl. Acad. Sci. USA 1976, 73, 2991-2994.
134. Miwa, J.M.; Ibanez-Tallon, I.; Crabtree, G.W.; Sanchez, R.; Sali, A.; Role, L.W.; Heintz, N. Lynx1, an endogenous toxin-like modulator of nicotinic acetylcholine receptors in the mammalian CNS. Neuron 1999, 23, 105-114.
135. Lyukmanova, E.N.; Shenkarev, Z.O.; Shulepko, M.A.; Mineev, K.S.; D'Hoedt, D.; Kasheverov, I.E.; Filkin, S.Y.; Krivolapova, A.P.; Janickova, H.; Dolezal, V.; Dolgikh, D.A.; Arseniev, A.S.; Bertrand, D.; Tsetlin, V.I.; Kirpichnikov, M.P. Nmr Structure and Action on Nicotinic Acetylcholine Receptors of Water-Soluble Domain of Human Lynx1. J. Biol. Chem. 2011, doi:10,1074/jbc.M110.189100.
136. Pawlak, J.; Mackessy, S.P.; Fry, B.G.; Bhatia, M.; Mourier, G.; Fruchart-Gaillard, C.; Servent, D.; Menez, R.; Stura, E.; Menez, A.; Kini, R.M. Denmotoxin, a three-finger toxin from the colubrid snake Boiga dendrophila (Mangrove Catsnake) with bird-specific activity. J. Biol. Chem. 2006, 281, 29030-29041.
137. Tsai, M.C.; Hsieh, W.H.; Smith, L.A.; Lee, C.Y. Effects of waglerin-I on neuromuscular transmission of mouse nerve-muscle preparations. Toxicon 1995, 33, 363-371.
138. Utkin, Y.N.; Kukhtina, V.V.; Kryukova, E.V.; Chiodini, F.; Bertrand, D.; Methfessel, C.; Tsetlin, V.I. Weak toxin from Naja kaouthia is a nontoxic antagonist of alpha. 7 and muscle-type nicotinic acetylcholine receptors. J. Biol. Chem. 2001, 276, 15810-15815.
139. Nirthanan, S.; Charpantier, E.; Gopalakrishnakone, P.; Gwee, M.C.; Khoo, H.E.; Cheah, L.S.; Bertrand, D.; Kini, R.M. Candoxin, a novel toxin from Bungarus candidus, is a reversible antagonist of muscle (alphabetagammadelta) but a poorly reversible antagonist of neuronal alpha. 7 nicotinic acetylcholine receptors. J. Biol. Chem. 2002, 277, 17811-17820.
140. Joubert, F.J.; Taljaard, N. Naja haje haje (Egyptian cobra) venom. Some properties and the complete primary structure of three toxins (CM-2, CM-11 and CM-12). Eur. J. Biochem. 1978, 90, 359-367.
141. Harvey, A.L.; Hider, R.C.; Hodges, S.J.; Joubert, F.J. Structure-activity studies of homologues of short chain neurotoxins from Elapid snake venoms. Br. J. Pharmacol. 1984, 82, 709-716.
142. Carlsson, F.H. Snake venom toxins. The primary structure of protein S4C11. A neurotoxin homologue from the venom of forest cobra (Naja melanoleuca). Biochim. Biophys. Acta. 1975, 400, 310-321.
143. Joubert, F.J.; Taljaard, N. Some properties and the complete primary structures of two reduced and S-carboxymethylated polypeptides (S5C1 and S5C10) from Dendroaspis jamesoni kaimosae (Jameson's mamba) venom. Biochim. Biophys. Acta 1979, 579, 228-233.
144. Aird, S.D.; Womble, G.C.; Yates, J.R., 3rd; Griffin, P.R. Primary structure of gamma-bungarotoxin, a new postsynaptic neurotoxin from venom of Bungarus multicinctus. Toxicon 1999, 37, 609-625.
145. Poh, S.L.; Mourier, G.; Thai, R.; Armugam, A.; Molgo, J.; Servent, D.; Jeyaseelan, K.; Menez, A. A synthetic weak neurotoxin binds with low affinity to Torpedo and chicken alpha7 nicotinic acetylcholine receptors. Eur. J. Biochem. 2002, 269, 4247-4256.
146. Chang, L.; Lin, S.; Wang, J.; Hu, W.P.; Wu, B.; Huang, H. Structure-function studies on Taiwan cobra long neurotoxin homolog. Biochim. Biophys. Acta. 2000, 1480, 293-301.
147. Harvey, A.L.; Rodger, I.W. Reversibility of neuromuscular blockade produced by toxins isolated from the venom of the seasnake Laticauda semifasciata. Toxicon 1978, 16, 219-225.
148. Brier, T.J.; Mellor, I.R.; Tikhonov, D.B.; Neagoe, I.; Shao, Z.; Brierley, M.J.; Stromgaard, K.; Jaroszewski, J.W.; Krogsgaard-Larsen, P.; Usherwood, P.N. Contrasting actions of philanthotoxin-343 and philanthotoxin-(12) on human muscle nicotinic acetylcholine receptors. Mol. Pharmacol. 2003, 64, 954-964.
149. Shu, Q.; Liang, S.P. Purification and characterization of huwentoxin-II, a neurotoxic peptide from the venom of the Chinese bird spider Selenocosmia huwena. J. Pept. Res. 1999, 53, 486-491.
150. Liang, S.P.; Zhang, D.Y.; Pan, X.; Chen, Q.; Zhou, P.A. Properties and amino acid sequence of huwentoxin-I, a neurotoxin purified from the venom of the Chinese bird spider Selenocosmia huwena. Toxicon 1993, 31, 969-978.
151. Daly, J.W. Nicotinic agonists, antagonists, and modulators from natural sources. Cell Mol. Neurobiol. 2005, 25, 513-552.
152. Barlow, R.B.; McLeod, L.J. Some studies on cytisine and its methylated derivatives. Br. J. Pharmacol. 1969, 35, 161-174.
153. Osswald, J.; Rellan, S.; Gago, A.; Vasconcelos, V. Toxicology and detection methods of the alkaloid neurotoxin produced by cyanobacteria, anatoxin-a. Environ. Int. 2007, 33, 1070-1089.
154. Merel, S.; Clement, M.; Thomas, O. State of the art on cyanotoxins in water and their behaviour towards chlorine. Toxicon 2010, 55, 677-691.
155. Araoz, R.; Vilarino, N.; Botana, L.M.; Molgo, J. Ligand-binding assays for cyanobacterial neurotoxins targeting cholinergic receptors. Anal. Bioanal. Chem. 2010, 397, 1695-1704.
156. Badio, B.; Daly, J.W. Epibatidine, a potent analgetic and nicotinic agonist. Mol. Pharmacol. 1994, 45, 563-569.
157. Kem, W.R.; Mahnir, V.M.; Papke, R.L.; Lingle, C.J. Anabaseine is a potent agonist on muscle and neuronal alpha-bungarotoxin-sensitive nicotinic receptors. J. Pharmacol. Exp. Ther. 1997, 283, 979-992.
158. Spivak, C.E.; Maleque, M.A.; Oliveira, A.C.; Masukawa, L.M.; Tokuyama, T.; Daly, J.W.; Albuquerque, E.X. Actions of the histrionicotoxins at the ion channel of the nicotinic acetylcholine receptor and at the voltage-sensitive ion channels of muscle membranes. Mol. Pharmacol. 1982, 21, 351-361.
159. Bick, R.C., Gillard, J.W., Leow, H.-M. Alkaloids of Darlingia ferruginea.Australian Australian. J. Chem. 1979, 32, 2537-2543.
160. Van Maanen, E.F. The antagonism between acetylcholine and the curare alkaloids, d-tubocurarine, c-curarine-I, c-toxiferine-II and beta-erythroidine in the rectus abdominis of the frog. J. Pharmacol. Exp. Ther. 1950, 99, 255-264.
161. Jensen, A.A.; Zlotos, D.P.; Liljefors, T. Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor. J. Med. Chem. 2007, 50, 4616-4629.
162. Tay, G. Diallyl nor-Toxiferine -a New Relaxant. Singapore Med. J. 1963, 141, 90-92.
163. Kosuge, T.; Tsuji, K.; Hirai, K. Isolation of neosurugatoxin from the Japanese ivory shell, Babylonia japonica. Chem. Pharm. Bull (Tokyo) 1982, 30, 3255-3259.
164. Hayashi, E., Isogai, M., Kagawa, Y., Takayanagi, N., Yamada, S. Neosurugatoxin, a specific antagonist of nicotinic acetylcholine receptors. J. Neurochem. 1984, 42, 1491-1494.
165. Hayashi, E.; Yamada, S. Pharmacological studies on surugatoxin, the toxic principle from Japanese ivory mollusc (Babylonia japonica). Br. J. Pharmacol. 1975, 53, 207-215.
166. Tornoe, C.; Bai, D.; Holden-Dye, L.; Abramson, S.N.; Sattelle, D.B. Actions of neurotoxins (bungarotoxins, neosurugatoxin and lophotoxins) on insect and nematode nicotinic acetylcholine receptors. Toxicon 1995, 33, 411-424.
167. Maciulaitis, R.; Kontrimaviciute, V.; Bressolle, F.M.; Briedis, V. Ibogaine, an anti-addictive drug: Pharmacology and time to go further in development. A narrative review. Hum. Exp. Toxicol. 2008, 27, 181-194.
168. Mash, D.C.; Kovera, C.A.; Buck, B.E.; Norenberg, M.D.; Shapshak, P.; Hearn, W.L.; Sanchez-Ramos, J. Medication development of ibogaine as a pharmacotherapy for drug dependence. Ann. N. Y. Acad. Sci. 1998, 844, 274-292.
169. Matsubayashi, H.; Alkondon, M.; Pereira, E.F.; Swanson, K.L.; Albuquerque, E.X. Strychnine: A potent competitive antagonist of alpha-bungarotoxin-sensitive nicotinic acetylcholine receptors in rat hippocampal neurons. J. Pharmacol. Exp. Ther. 1998, 284, 904-913.
170. Francis, M.M.; Cheng, E.Y.; Weiland, G.A.; Oswald, R.E. Specific activation of the alpha. 7 nicotinic acetylcholine receptor by a quaternary analog of cocaine. Mol. Pharmacol. 2001, 60, 71-79.
171. Haefely, W. The effects of various nicotine-like agents in the cat superior cervical ganglion in situ. Naunyn. Schmiedebergs. Arch. Pharmacol. 1974, 281, 93-117.
172. Sakurai, Y.; Takano, Y.; Kohjimoto, Y.; Honda, K.; Kamiya, H.O. Enhancement of [3H]dopamine release and its [3H]metabolites in rat striatum by nicotinic drugs. Brain. Res. 1982, 242, 99-106.
173. Rozman, K.B.; Araoz, R.; Sepcic, K.; Molgo, J.; Suput, D. Parazoanthoxanthin A blocks Torpedo nicotinic acetylcholine receptors. Chem. Biol. Interact. 2010, 187, 384-387.
174. Culver, P.; Burch, M.; Potenza, C.; Wasserman, L.; Fenical, W.; Taylor, P. Structure-activity relationships for the irreversible blockade of nicotinic receptor agonist sites by lophotoxin and congeneric diterpene lactones. Mol. Pharmacol. 1985, 28, 436-444.
175. Culver, P.; Fenical, W.; Taylor, P. Lophotoxin irreversibly inactivates the nicotinic acetylcholine receptor by preferential association at one of the two primary agonist sites. J. Biol. Chem. 1984, 259, 3763-3770.
176. Culver, P.; Jacobs, R.S. Lophotoxin: A neuromuscular acting toxin from the sea whip (Lophogorgia rigida). Toxicon 1981, 19, 825-830.
177. Fenical, W.; Okuda, R.K.; Bandurraga, M.M.; Culver, P.; Jacobs, R.S. Lophotoxin: A novel neuromuscular toxin from Pacific sea whips of the genus Lophogorgia. Science 1981, 212, 1512-1514.
178. Luetje, C.W.; Wada, K.; Rogers, S.; Abramson, S.N.; Tsuji, K.; Heinemann, S.; Patrick, J. Neurotoxins distinguish between different neuronal nicotinic acetylcholine receptor subunit combinations. J. Neurochem. 1990, 55, 632-640.
179. Abramson, S.N.; Li, Y.; Culver, P.; Taylor, P. An analog of lophotoxin reacts covalently with Tyr190 in the alpha-subunit of the nicotinic acetylcholine receptor. J. Biol. Chem. 1989, 264, 12666-12672.
180. Holmskov, U.; Laursen, S.B.; Malhotra, R.; Wiedemann, H.; Timpl, R.; Stuart, G.R.; Tornoe, I.; Madsen, P.S.; Reid, K.B.; Jensenius, J.C. Comparative study of the structural and functional properties of a bovine plasma C-type lectin, collectin-43, with other collectins. Biochem. J. 1995, 305, 889-896.
181. Johnston, G.A.; Hanrahan, J.R.; Chebib, M.; Duke, R.K.; Mewett, K.N. Modulation of ionotropic GABA receptors by natural products of plant origin. Adv. Pharmacol. 2006, 54, 285-316.
182. Takemoto, T.; Nakajima, T.; Sakuma, R. Isolation of a Flycidal Constituent Ibotenic Acid from Amanita Muscaria and A. Pantherina. Yakugaku. Zasshi. 1964, 84, 1233-1234.
183. Takemoto, T.; Nakajima, T.; Yokobe, T. Structure of Ibotenic Acid. Yakugaku. Zasshi. 1964, 84, 1232-1233.
184. Casarett, L.J.; Doull, J.; Klaassen, C.D. Casarett and. Doull's Toxicology: The Basic Science of Poisons, 7th ed.; McGraw-Hill Medical; London, UK, 2008; p. 1236.
185. Shin-ya, K., Kim, J.-S., Furihata, K., Hayakawa, Y., Seto, H. Structure of kaitocephalin, a novel glutamate receptor antagonist produced by Eupenicillium shearii. Tetrahedron. Lett. 1997, 36, 7079-7082.
186. Limon, A.; Reyes-Ruiz, J.M.; Vaswani, R.G.; Chamberlin, A.R.; Miledi, R. Kaitocephalin antagonism of glutamate receptors expressed in Xenopus oocytes. ACS. Chem. Neurosci. 2010, 1, 175-181.
187. Reis, H.J.; Prado, M.A.; Kalapothakis, E.; Cordeiro, M.N.; Diniz, C.R.; De Marco, L.A.; Gomez, M.V.; Romano-Silva, M.A. Inhibition of glutamate uptake by a polypeptide toxin (phoneutriatoxin. 3-4) from the spider Phoneutria nigriventer. Biochem. J. 1999, 343, 413-418.
188. Mafra, R.A.; Figueiredo, S.G.; Diniz, C.R.; Cordeiro, M.N.; Cruz, J.D.; De Lima, M.E. PhTx4, a new class of toxins from Phoneutria nigriventer spider venom, inhibits the glutamate uptake in rat brain synaptosomes. Brain. Res. 1999, 831, 297-300.
189. de Figueiredo, S.G.; de Lima, M.E.; Nascimento Cordeiro, M.; Diniz, C.R.; Patten, D.; Halliwell, R.F.; Gilroy, J.; Richardson, M. Purification and amino acid sequence of a highly insecticidal toxin from the venom of the brazilian spider Phoneutria nigriventer which inhibits NMDA-evoked currents in rat hippocampal neurones. Toxicon 2001, 39, 309-317.
190. Piek, T. Neurotoxins from venoms of the Hymenoptera--twenty-five years of research in Amsterdam. Comp. Biochem. Physiol. C 1990, 96, 223-233.
191. Clark, R.B.; Donaldson, P.L.; Gration, K.A.; Lambert, J.J.; Piek, T.; Ramsey, R.; Spanjer, W.; Usherwood, P.N. Block of locust muscle glutamate receptors by delta-philanthotoxin occurs after receptor activations. Brain. Res. 1982, 241, 105-114.
192. Hagan, R.M.; Jones, B.J.; Jordan, C.C.; Tyers, M.B. Effect of 5-HT3 receptor antagonists on responses to selective activation of mesolimbic dopaminergic pathways in the rat. Br. J. Pharmacol. 1990, 99, 227-232.
193. Andersen, T.F.; Tikhonov, D.B.; Bolcho, U.; Bolshakov, K.; Nelson, J.K.; Pluteanu, F.; Mellor, I.R.; Egebjerg, J.; Stromgaard, K. Uncompetitive antagonism of AMPA receptors: Mechanistic insights from studies of polyamine toxin derivatives. J. Med. Chem. 2006, 49, 5414-5423.
194. Rash, L.D.; Hodgson, W.C. Pharmacology and biochemistry of spider venoms. Toxicon 2002, 40, 225-254.
195. Brackley, P.T.; Bell, D.R.; Choi, S.K.; Nakanishi, K.; Usherwood, P.N. Selective antagonism of native and cloned kainate and NMDA receptors by polyamine-containing toxins. J. Pharmacol. Exp. Ther. 1993, 266, 1573-1580.
196. Chiba, T.; Akizawa, T.; Matsukawa, M.; Pan-Hou, H.; Yoshioka, M. Finding of primitive polyamine toxins in the venom of a joro spider, Nephila clavata. Chem. Pharm. Bull (Tokyo) 1994, 42, 1864-1869.
197. Sorkin, L.S.; Yaksh, T.L.; Doom, C.M. Pain models display differential sensitivity to Ca2+-permeable non-NMDA glutamate receptor antagonists. Anesthesiology. 2001, 95, 965-973.
198. Gmelin, R. The free amino acids in the seeds of Acacia willardiana (Mimosaceae). Isolation of willardiin, a new plant amino acid which is probably L-beta-(3-uracil)-alpha-aminopropionic acid. Hoppe. Seylers. Z. Physiol. Chem. 1959, 316, 164-169.
199. Evans, R.H.; Jones, A.W.; Watkins, J.C. Willardiine: A potent quisqualate-like excitant. J. Physiol (Lond) 1980, 308, 71-72.
200. Shinozaki, H.; Ishida, M. Excitatory amino acids: Physiological and pharmacological probes for neuroscience research. Acta. Neurobiol. Exp (Wars) 1993, 53, 43-51.
201. Scallet, A.C.; Ye, X. Excitotoxic mechanisms of neurodegeneration in transmissible spongiform encephalopathies. Ann. NY. Acad. Sci. 1997, 825, 194-205.
202. Agrawal, B.B., Goldstein, I.J. Protein-carbohydrate interaction. VI. Isolation of concanavalin A by specific adsorption on cross-linked dextran gels. Biochim. Biophys. Acta. 1967, 147, 262-271.
203. Bowie, D.; Garcia, E.P.; Marshall, J.; Traynelis, S.F.; Lange, G.D. Allosteric regulation and spatial distribution of kainate receptors bound to ancillary proteins. J. Physiol. 2003, 547, 373-385.
204. Boland, L.M.; Morrill, J.A.; Bean, B.P. Omega-Conotoxin block of N-type calcium channels in frog and rat sympathetic neurons. J. Neurosci. 1994, 14, 5011-5027.
205. Lalo, U.V.; Pankratov, Y.V.; Arndts, D.; Krishtal, O.A. Omega-conotoxin GVIA potently inhibits the currents mediated by P2X receptors in rat DRG neurons. Brain. Res. Bull. 2001, 54, 507-512.
206. Skals, M.; Jorgensen, N.R.; Leipziger, J.; Praetorius, H.A. Alpha-hemolysin from Escherichia coli uses endogenous amplification through P2X receptor activation to induce hemolysis. Proc. Natl. Acad. Sci. USA 2009, 106, 4030-4035.
207. Yilmaz, O.; Yao, L.; Maeda, K.; Rose, T.M.; Lewis, E.L.; Duman, M.; Lamont, R.J.; Ojcius, D.M. ATP scavenging by the intracellular pathogen Porphyromonas gingivalis inhibits P2X7-mediated host-cell apoptosis. Cell Microbiol. 2008, 10, 863-875.
208. Csolle, C.; Sperlagh, B. Peripheral origin of IL-1beta production in the rodent hippocampus under in vivo systemic bacterial lipopolysaccharide (LPS) challenge and its regulation by P2X(7) receptors. J. Neuroimmunol. 2010, 219, 38-46.
209. Verstrepen, L.; Bekaert, T.; Chau, T.L.; Tavernier, J.; Chariot, A.; Beyaert, R. TLR-4, IL-1R and TNF-R signaling to NF-kappaB: Variations on a common theme. Cell Mol. Life. Sci. 2008, 65, 2964-2978.
210. Cameron, D.J. Inhibition of macrophage mediated cytotoxicity by exogenous adenosine. 5'-triphosphate. J. Clin. Lab. Immunol. 1984, 15, 215-218.
211. Schilling, W.P.; Wasylyna, T.; Dubyak, G.R.; Humphreys, B.D.; Sinkins, W.G. Maitotoxin and P2Z/P2X(7) purinergic receptor stimulation activate a common cytolytic pore. Am. J. Physiol. 1999, 277, C766-776.
212. Lundy, P.M.; Nelson, P.; Mi, L.; Frew, R.; Minaker, S.; Vair, C.; Sawyer, T.W. Pharmacological differentiation of the P2X7 receptor and the maitotoxin-activated cationic channel. Eur. J. Pharmacol. 2004, 487, 17-28.